|
US6605712B1
(en)
|
1990-12-20 |
2003-08-12 |
Arch Development Corporation |
Gene transcription and ionizing radiation: methods and compositions
|
|
AU1328595A
(en)
*
|
1994-06-20 |
1996-01-15 |
Auckland Uniservices Limited |
Brain damage monitor
|
|
GB9524968D0
(en)
*
|
1995-12-06 |
1996-02-07 |
Brown Brian H |
Impedance pneumography
|
|
AU6230298A
(en)
*
|
1997-02-24 |
1998-09-09 |
Tanita Corporation |
Living body impedance measuring instrument and body composition measuring instrument
|
|
ES2142219B1
(es)
*
|
1997-03-06 |
2000-11-16 |
Nte Sa |
Procedimiento para determinar la composicion y calidad de sustancias de naturaleza carnica.
|
|
ES2151774B1
(es)
*
|
1997-03-06 |
2001-07-01 |
Nte Sa |
Aparato y procedimiento para la medida de volumenes y composicion corporal global y segmental en seres humanos.
|
|
ES2143911B1
(es)
*
|
1997-03-06 |
2000-12-01 |
Nte Sa |
Metodo y aparato para medir la concentracion y composicion de biomasa.
|
|
JP3125730B2
(ja)
*
|
1997-09-11 |
2001-01-22 |
憲一 山越 |
血行動態表示装置
|
|
US6153811A
(en)
|
1997-12-22 |
2000-11-28 |
Dekalb Genetics Corporation |
Method for reduction of transgene copy number
|
|
US6125297A
(en)
*
|
1998-02-06 |
2000-09-26 |
The United States Of America As Represented By The United States National Aeronautics And Space Administration |
Body fluids monitor
|
|
US6122544A
(en)
*
|
1998-05-01 |
2000-09-19 |
Organ; Leslie William |
Electrical impedance method and apparatus for detecting and diagnosing diseases
|
|
US6307123B1
(en)
|
1998-05-18 |
2001-10-23 |
Dekalb Genetics Corporation |
Methods and compositions for transgene identification
|
|
EP1141685B1
(de)
*
|
1999-01-05 |
2005-02-23 |
Kaiku Limited |
Impedanzmessungen von teilen aus menschlichen oder tierischen körpern
|
|
US6429357B1
(en)
|
1999-05-14 |
2002-08-06 |
Dekalb Genetics Corp. |
Rice actin 2 promoter and intron and methods for use thereof
|
|
AUPQ113799A0
(en)
*
|
1999-06-22 |
1999-07-15 |
University Of Queensland, The |
A method and device for measuring lymphoedema
|
|
US6387671B1
(en)
*
|
1999-07-21 |
2002-05-14 |
The Regents Of The University Of California |
Electrical impedance tomography to control electroporation
|
|
EP1217942A1
(de)
|
1999-09-24 |
2002-07-03 |
Healthetech, Inc. |
Physiologisches überwachungsgerät und damit verbundener computer, anzeigegerät und kommunikationseinheit
|
|
JP3705574B2
(ja)
*
|
1999-09-30 |
2005-10-12 |
株式会社タニタ |
生体電気インピーダンス測定装置
|
|
US7499745B2
(en)
*
|
2000-02-28 |
2009-03-03 |
Barbara Ann Karmanos Cancer Institute |
Multidimensional bioelectrical tissue analyzer
|
|
US6482158B2
(en)
|
2000-05-19 |
2002-11-19 |
Healthetech, Inc. |
System and method of ultrasonic mammography
|
|
US6607387B2
(en)
|
2000-10-30 |
2003-08-19 |
Healthetech, Inc. |
Sensor system for diagnosing dental conditions
|
|
AU2002218496A1
(en)
*
|
2000-11-29 |
2002-06-11 |
Art Haven 9 Co., Ltd. |
Method and device for measuring body compositions
|
|
US6768921B2
(en)
*
|
2000-12-28 |
2004-07-27 |
Z-Tech (Canada) Inc. |
Electrical impedance method and apparatus for detecting and diagnosing diseases
|
|
FI109651B
(fi)
|
2001-03-23 |
2002-09-30 |
Delfin Technologies Ltd |
Menetelmä kudosturvotuksen mittaamiseksi
|
|
US8034791B2
(en)
|
2001-04-06 |
2011-10-11 |
The University Of Chicago |
Activation of Egr-1 promoter by DNA damaging chemotherapeutics
|
|
ES2184609B1
(es)
*
|
2001-04-27 |
2004-06-16 |
Nte S.A. |
Metodo y aparato de obtencion de caracteristicas fisicas y/o quimicas de un medio biologico.
|
|
JP4338402B2
(ja)
|
2001-05-22 |
2009-10-07 |
ユニバーシティ オブ シカゴ |
Ｎ４ウイルス一本鎖ｄｎａ依存的ｒｎａポリメラーゼ
|
|
IL143374A0
(en)
*
|
2001-05-24 |
2002-04-21 |
Transscan Medical Ltd |
Anomaly detection based on signal variations
|
|
CA2449567A1
(en)
*
|
2001-06-13 |
2002-12-19 |
Ckm Diagnostics, Inc. |
Non-invasive method and apparatus for tissue detection
|
|
BR0213965A
(pt)
|
2001-10-26 |
2005-03-15 |
Baylor College Medicine |
Composição e método para alterar as propriedades de massa corporal magra e ósseas em um indivìduo
|
|
WO2003049700A2
(en)
|
2001-12-11 |
2003-06-19 |
Advisys, Inc. |
Growth hormone releasing hormone suplementation for treating chronically ill subjects
|
|
WO2003059164A2
(en)
|
2002-01-15 |
2003-07-24 |
Orsan Medical Equipment Ltd. |
Device for monitoring blood flow to brain
|
|
US7998080B2
(en)
*
|
2002-01-15 |
2011-08-16 |
Orsan Medical Technologies Ltd. |
Method for monitoring blood flow to brain
|
|
US8211031B2
(en)
*
|
2002-01-15 |
2012-07-03 |
Orsan Medical Technologies Ltd. |
Non-invasive intracranial monitor
|
|
JP4105472B2
(ja)
*
|
2002-04-12 |
2008-06-25 |
株式会社フィジオン |
身体組成測定装置
|
|
EP1549133B1
(de)
|
2002-05-22 |
2015-04-22 |
Monsanto Technology LLC |
Fettsäuredesaturasen von pilzen
|
|
US7907998B2
(en)
|
2002-07-03 |
2011-03-15 |
Tel Aviv University Future Technology Development L.P. |
Bio-impedance apparatus and method
|
|
US7096061B2
(en)
*
|
2002-07-03 |
2006-08-22 |
Tel-Aviv University Future Technology Development L.P. |
Apparatus for monitoring CHF patients using bio-impedance technique
|
|
AU2003304195B8
(en)
|
2002-07-15 |
2008-08-28 |
Board Of Regents, The University Of Texas System |
Combinatorial protein library screening by periplasmic expression
|
|
EP1578396A4
(de)
|
2002-08-12 |
2007-01-17 |
David Kirn |
Verfahren und zusammensetzungen gegen pockenviren und krebs
|
|
AU2002951925A0
(en)
*
|
2002-10-09 |
2002-10-24 |
Queensland University Of Technology |
An Impedence Cardiography Device
|
|
EP1562471A4
(de)
*
|
2002-10-17 |
2009-03-25 |
Gen Hospital Corp |
Anordnung und verfahren zum nachweis von anomalien und abweichungen in einem körper
|
|
US20030126593A1
(en)
*
|
2002-11-04 |
2003-07-03 |
Mault James R. |
Interactive physiological monitoring system
|
|
US7404950B2
(en)
|
2003-02-18 |
2008-07-29 |
Baylor College Of Medicine |
Induced activation in dendritic cell
|
|
WO2004082460A2
(en)
*
|
2003-03-14 |
2004-09-30 |
Shock, Llc |
Methods of and apparatus for determining fluid volume presence in mammalian tissue
|
|
WO2004091390A2
(en)
|
2003-04-15 |
2004-10-28 |
Philips Intellectual Property & Standards Gmbh |
Device and method for examination and use of an electrical field in an object under examination containing magnetic particles
|
|
DE10339084B4
(de)
*
|
2003-08-26 |
2015-10-29 |
Drägerwerk AG & Co. KGaA |
Elektroimpedanztomographie-Gerät
|
|
CN101926647B
(zh)
*
|
2003-09-12 |
2013-06-05 |
肾脏研究所有限公司 |
生物阻抗方法和仪器
|
|
US20080076998A1
(en)
*
|
2003-12-01 |
2008-03-27 |
Z-Tech (Canada) Inc. |
Breast electrode array and method of analysis for detecting and diagnosing diseases
|
|
WO2005065090A2
(en)
*
|
2003-12-30 |
2005-07-21 |
The Mitre Corporation |
Techniques for building-scale electrostatic tomography
|
|
JP4646614B2
(ja)
*
|
2004-03-01 |
2011-03-09 |
株式会社タニタ |
体組成測定装置
|
|
JP4848369B2
(ja)
|
2004-06-18 |
2011-12-28 |
インぺディメッド リミテッド |
浮腫検出のための装置と該動作方法
|
|
US8068906B2
(en)
|
2004-06-21 |
2011-11-29 |
Aorora Technologies Pty Ltd |
Cardiac monitoring system
|
|
JP4904263B2
(ja)
|
2004-07-15 |
2012-03-28 |
オーサン メディカル テクノロジーズ リミテッド |
脳灌流監視装置
|
|
WO2006044868A1
(en)
*
|
2004-10-20 |
2006-04-27 |
Nervonix, Inc. |
An active electrode, bio-impedance based, tissue discrimination system and methods and use
|
|
US20060085048A1
(en)
*
|
2004-10-20 |
2006-04-20 |
Nervonix, Inc. |
Algorithms for an active electrode, bioimpedance-based tissue discrimination system
|
|
ES2534304T3
(es)
|
2004-11-12 |
2015-04-21 |
Asuragen, Inc. |
Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
|
|
CA2528303A1
(en)
|
2004-11-26 |
2006-05-26 |
Z-Tech (Canada) Inc. |
Weighted gradient method and system for diagnosing disease
|
|
US8109981B2
(en)
*
|
2005-01-25 |
2012-02-07 |
Valam Corporation |
Optical therapies and devices
|
|
DE102005022896B3
(de)
*
|
2005-05-18 |
2006-05-11 |
Dräger Medical AG & Co. KG |
Vorrichtung und Verfahren zur Steuerung eines Beatmungsgerätes
|
|
AU2006265763B2
(en)
|
2005-07-01 |
2012-08-09 |
Impedimed Limited |
Monitoring system
|
|
EP1903938A4
(de)
*
|
2005-07-01 |
2010-01-20 |
Impedance Cardiology Systems I |
Lungenüberwachungssystem
|
|
AU2006265761B2
(en)
|
2005-07-01 |
2011-08-11 |
Impedimed Limited |
Monitoring system
|
|
EP1909642A1
(de)
*
|
2005-07-20 |
2008-04-16 |
Impedance Cardiology Systems Inc. |
Indexbestimmung
|
|
US8099250B2
(en)
*
|
2005-08-02 |
2012-01-17 |
Impedimed Limited |
Impedance parameter values
|
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
|
CA2621982C
(en)
|
2005-09-07 |
2017-11-28 |
Jennerex Biotherapeutics Ulc |
Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
|
|
ES2476999T3
(es)
|
2005-10-11 |
2014-07-15 |
Impedimed Limited |
Monitorización del estado de hidratación
|
|
CA2637598A1
(en)
|
2006-01-18 |
2007-02-14 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
|
US8600497B1
(en)
*
|
2006-03-31 |
2013-12-03 |
Pacesetter, Inc. |
Systems and methods to monitor and treat heart failure conditions
|
|
US7794404B1
(en)
|
2006-03-31 |
2010-09-14 |
Pacesetter, Inc |
System and method for estimating cardiac pressure using parameters derived from impedance signals detected by an implantable medical device
|
|
ES2545730T3
(es)
*
|
2006-05-30 |
2015-09-15 |
Impedimed Limited |
Mediciones de impedancia
|
|
WO2008014484A1
(en)
|
2006-07-27 |
2008-01-31 |
University Of Maryland, Baltimore |
Cellular receptor for antiproliferative factor
|
|
JP5606067B2
(ja)
|
2006-09-15 |
2014-10-15 |
オタワ ホスピタル リサーチ インスティテュート |
腫瘍崩壊性ラブドウイルス
|
|
US8691210B2
(en)
|
2006-10-19 |
2014-04-08 |
David M Spencer |
Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
|
|
AU2007351787A1
(en)
|
2006-10-20 |
2008-10-30 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Modified cyanobacteria
|
|
JP5372768B2
(ja)
|
2006-11-30 |
2013-12-18 |
インぺディメッド リミテッド |
測定装置
|
|
EP2102239B1
(de)
|
2006-11-30 |
2012-04-25 |
Research Development Foundation |
Verbesserte immunglobulin-bibliotheken
|
|
CA2675438A1
(en)
*
|
2007-01-15 |
2008-07-24 |
Impedimed Limited |
Monitoring system
|
|
KR20080084528A
(ko)
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
종양살상형 백시니아 바이러스 암 치료
|
|
AU2008234370B2
(en)
*
|
2007-03-30 |
2011-06-30 |
Impedimed Limited |
Active guarding for reduction of resistive and capactive signal loading with adjustable control of compensation level
|
|
US8208999B2
(en)
|
2007-04-04 |
2012-06-26 |
Pacesetter, Inc. |
System and method for estimating electrical conduction delays from immittance values measured using an implantable medical device
|
|
US8504153B2
(en)
|
2007-04-04 |
2013-08-06 |
Pacesetter, Inc. |
System and method for estimating cardiac pressure based on cardiac electrical conduction delays using an implantable medical device
|
|
JP5419861B2
(ja)
*
|
2007-04-20 |
2014-02-19 |
インぺディメッド リミテッド |
インピーダンス測定装置および方法
|
|
US8629245B2
(en)
|
2007-05-01 |
2014-01-14 |
Research Development Foundation |
Immunoglobulin Fc libraries
|
|
US7596411B1
(en)
|
2007-06-08 |
2009-09-29 |
Pacesetter, Inc. |
Apparatus and method for two-component bioelectrical impedance ratio measuring and monitoring
|
|
WO2009018620A1
(en)
*
|
2007-08-09 |
2009-02-12 |
Impedimed Limited |
Impedance measurement process
|
|
WO2009029831A1
(en)
|
2007-08-31 |
2009-03-05 |
University Of Chicago |
Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
|
|
CA2704061C
(en)
*
|
2007-11-05 |
2017-06-20 |
Impedimed Limited |
Impedance determination
|
|
KR101588736B1
(ko)
|
2008-01-10 |
2016-01-26 |
리서치 디벨롭먼트 파운데이션 |
얼리키아 샤피엔시스에 대한 백신 및 진단제
|
|
JP5674476B2
(ja)
|
2008-01-25 |
2015-02-25 |
ピー５３ インコーポレイテッド |
Ｐ５３バイオマーカー
|
|
WO2009096821A1
(en)
*
|
2008-01-29 |
2009-08-06 |
St.Jude Medical Ab |
Method and implantable medical device (imd) for monitoring permeability status of cell membranes.
|
|
AU2008207672B2
(en)
*
|
2008-02-15 |
2013-10-31 |
Impedimed Limited |
Impedance Analysis
|
|
CA2954948A1
(en)
|
2008-06-04 |
2009-12-10 |
Cellular Dynamics International, Inc. |
Methods for the production of ips cells using non-viral approach
|
|
CN107988261A
(zh)
|
2008-08-12 |
2018-05-04 |
细胞动力国际有限公司 |
产生ips细胞的方法
|
|
AU2009282625A1
(en)
|
2008-08-18 |
2010-02-25 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Derivatives of APF and methods of use
|
|
JP6133538B2
(ja)
|
2008-09-22 |
2017-05-24 |
ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ |
Ｃｄ４０およびパターン認識受容体アダプターを誘発することによる免疫応答を生成するための方法および組成物
|
|
AU2009302582A1
(en)
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions and methods related to bacterial Eap, Emp, and/or AdsA proteins
|
|
CN102238906B
(zh)
*
|
2008-10-07 |
2013-11-06 |
奥森医疗科技有限公司 |
急性中风的诊断
|
|
GB0820309D0
(en)
*
|
2008-11-06 |
2008-12-17 |
Middlesex University Higher Ed |
Detection of cancer
|
|
EP2348987B1
(de)
|
2008-11-28 |
2017-03-22 |
Impedimed Limited |
Impedanz-messverfahren
|
|
JP5651125B2
(ja)
|
2008-12-10 |
2015-01-07 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
Ｍｅｋ阻害剤に対する耐性を付与するｍｅｋ突然変異
|
|
JP2012515532A
(ja)
|
2009-01-20 |
2012-07-12 |
ラモット アット テル アビブ ユニバーシティ， リミテッド |
Ｍｉｒ−２１プロモーター駆動性標的がん治療
|
|
US8764672B2
(en)
*
|
2009-02-17 |
2014-07-01 |
Preston K. Manwaring |
System, method and device for monitoring the condition of an internal organ
|
|
WO2010096510A2
(en)
|
2009-02-17 |
2010-08-26 |
Edenspace Systems Corporation |
Tempering of cellulosic biomass
|
|
KR101773368B1
(ko)
|
2009-04-03 |
2017-08-31 |
유니버시티 오브 시카고 |
단백질 Ａ(ＳｐＡ) 변이체와 관련된 조성물 및 방법
|
|
EP3061766B1
(de)
|
2009-04-28 |
2019-12-25 |
Vanderbilt University |
Zusammensetzungen und verfahren zur behandlung von erkrankungen im zusammenhang mit epithelzellapoptose
|
|
US20120079627A1
(en)
|
2009-05-29 |
2012-03-29 |
Edenspace Systems Corporation |
Plant gene regulatory elements
|
|
CN102459575A
(zh)
|
2009-06-05 |
2012-05-16 |
细胞动力国际有限公司 |
重编程t细胞和造血细胞的方法
|
|
WO2011025826A1
(en)
|
2009-08-26 |
2011-03-03 |
Research Development Foundation |
Methods for creating antibody libraries
|
|
WO2011032180A1
(en)
|
2009-09-14 |
2011-03-17 |
Jennerex, Inc. |
Oncolytic vaccinia virus combination cancer therapy
|
|
US8937214B2
(en)
|
2009-10-23 |
2015-01-20 |
Monsanto Technology Llc |
Methods and compositions for expression of transgenes in plants
|
|
JP5643829B2
(ja)
|
2009-10-26 |
2014-12-17 |
インぺディメッド リミテッドＩｍｐｅｄｉｍｅｄ Ｌｉｍｉｔｅｄ |
インピーダンス測定の分析において用いるための方法及び装置
|
|
AU2010321683B2
(en)
|
2009-11-18 |
2014-06-26 |
Impedimed Limited |
Signal distribution for patient-electrode measurements
|
|
EP2510088B1
(de)
|
2009-12-10 |
2016-10-05 |
Ottawa Hospital Research Institute |
Onkolytisches rhabdovirus
|
|
WO2011100508A2
(en)
|
2010-02-12 |
2011-08-18 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
|
MX340392B
(es)
|
2010-02-25 |
2016-07-06 |
Dana Farber Cancer Inst Inc |
Mutaciones del protooncogen de serina/treonina-proteina cinasa b-raf (braf) que confieren resistencia a los inhibidores del protooncogen de serina/treonina-proteina cinasa b-raf.
|
|
EP2542678B1
(de)
|
2010-03-04 |
2017-04-12 |
InteRNA Technologies B.V. |
Mirna-molekül, das durch seine quelle definiert ist, und seine therapeutischen verwendungen bei emt assoziierten krebs
|
|
BR112012022801B8
(pt)
|
2010-03-09 |
2019-10-29 |
Dana Farber Cancer Inst Inc |
método de identificar um indivíduo que tem câncer que é provável beneficiar-se do tratamento com uma terapia de combinação com um inibidor de raf e um segundo inibidor e uso de um inibidor de raf e um segundo inibidor para a fabricação de um medicamento para tratar câncer
|
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
|
|
WO2011126976A1
(en)
|
2010-04-07 |
2011-10-13 |
Vanderbilt University |
Reovirus vaccines and methods of use therefor
|
|
DK2560672T3
(en)
|
2010-04-19 |
2014-03-17 |
Res Dev Foundation |
RTEF-1 variants and their uses
|
|
BR112012029422A2
(pt)
|
2010-05-19 |
2017-10-03 |
The Samuel Roberts Noble Found Inc |
Morfologia de folha alterada e propriedades agronômicas melhoradas em plantas
|
|
WO2011146862A1
(en)
|
2010-05-21 |
2011-11-24 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing selective apoptosis
|
|
EP3333259B1
(de)
|
2010-06-09 |
2021-02-24 |
Dana Farber Cancer Institute, Inc. |
Mek1-mutation für resistenz gegenüber raf- und mek-hemmern
|
|
CA2802087A1
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
A compendium of ready-built stem cell models for interrogation of biological response
|
|
CN103003416B
(zh)
|
2010-06-15 |
2016-11-16 |
细胞动力学国际有限公司 |
从小体积的外周血产生诱导性多潜能干细胞
|
|
CN103037885B
(zh)
|
2010-07-02 |
2015-08-26 |
芝加哥大学 |
与蛋白A(SpA)变体相关的组合物和方法
|
|
CA2804599C
(en)
|
2010-07-06 |
2023-01-31 |
Interna Technologies Bv |
Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
|
|
US8785192B2
(en)
|
2010-07-07 |
2014-07-22 |
Cellular Dynamics International, Inc. |
Endothelial cell production by programming
|
|
US8765470B2
(en)
|
2010-08-04 |
2014-07-01 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized B-cells to induced pluripotent stem cells
|
|
JP5793194B2
(ja)
|
2010-09-09 |
2015-10-14 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
感染防御ブドウ球菌抗原が関与する方法および組成物
|
|
CN103501803B
(zh)
|
2010-09-22 |
2015-12-02 |
科罗拉多大学董事会 |
Smad7的治疗应用
|
|
US9045549B2
(en)
|
2010-11-03 |
2015-06-02 |
The Samuel Roberts Noble Foundation, Inc. |
Transcription factors for modification of lignin content in plants
|
|
AU2012204467B2
(en)
|
2011-01-04 |
2016-08-18 |
Sillajen, Inc. |
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
|
|
EP2474617A1
(de)
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
MIR zur Behandlung von Neoangiogenese
|
|
CA2826467C
(en)
|
2011-02-07 |
2019-11-12 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides
|
|
JP6005666B2
(ja)
|
2011-02-08 |
2016-10-12 |
セルラー ダイナミクス インターナショナル， インコーポレイテッド |
プログラミングによる造血前駆細胞の生産
|
|
US20120203122A1
(en)
|
2011-02-09 |
2012-08-09 |
Opher Kinrot |
Devices and methods for monitoring cerebral hemodynamic conditions
|
|
EP3406628A1
(de)
|
2011-04-08 |
2018-11-28 |
Evaxion Biotech ApS |
In impfstoffen gegen staphylococcus aureus nützliche proteine und nukleinsäuren
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
EP2718427B1
(de)
|
2011-06-08 |
2017-01-11 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
Zusammensetzungen zur behandlung von glioblastomen
|
|
EP2732029B1
(de)
|
2011-07-11 |
2019-01-16 |
FUJIFILM Cellular Dynamics, Inc. |
Verfahren zur zellprogrammierung und genommanipulation
|
|
CA2845259A1
(en)
|
2011-08-15 |
2013-02-21 |
The University Of Chicago |
Compositions and methods related to antibodies to staphylococcal protein a
|
|
WO2013026015A1
(en)
|
2011-08-18 |
2013-02-21 |
Dana-Farber Cancer Institute, Inc. |
Muc1 ligand traps for use in treating cancers
|
|
US9273102B2
(en)
|
2011-10-12 |
2016-03-01 |
Niels Iversen Møller |
Peptides derived from Campylobacter jejuni and their use in vaccination
|
|
CA2858244A1
(en)
|
2011-12-14 |
2013-06-20 |
Intersection Medical, Inc. |
Devices, systems and methods for determining the relative spatial change in subsurface resistivities across frequencies in tissue
|
|
ES2886147T3
(es)
|
2011-12-22 |
2021-12-16 |
Interna Tech B V |
MiARN para el tratamiento del cáncer de cabeza y de cuello
|
|
EP2814389B1
(de)
*
|
2012-02-15 |
2022-09-21 |
Koninklijke Philips N.V. |
Bioimpedanzspektrographiesystem und -verfahren
|
|
CA2910320A1
(en)
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
|
|
EP2844275B1
(de)
|
2012-04-26 |
2020-05-13 |
University of Chicago |
Staphylokokken-coagulase-antigene und verfahren zu deren verwendung
|
|
WO2014022455A1
(en)
|
2012-07-31 |
2014-02-06 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions for in vivo induction of pancreatic beta cell formation
|
|
AU2013317586B2
(en)
|
2012-09-24 |
2017-12-07 |
Seminis Vegetable Seeds, Inc. |
Methods and compositions for extending shelf life of plant products
|
|
WO2014065945A1
(en)
|
2012-10-23 |
2014-05-01 |
The Board Of Regents Of The University Of Texas System |
Antibodies with engineered igg fc domains
|
|
US10201556B2
(en)
|
2012-11-06 |
2019-02-12 |
Interna Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
|
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
|
RU2684211C2
(ru)
|
2013-02-21 |
2019-04-04 |
Тёрнстоун Лимитед Партнершип |
Композиция вакцины
|
|
WO2014130770A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
|
DE102013203177A1
(de)
|
2013-02-26 |
2014-08-28 |
Hamilton Medical Ag |
System zur automatisierten Einstellung eines durch eine Beatmungseinrichtung vorgegebenen Drucks
|
|
US10086093B2
(en)
|
2013-02-28 |
2018-10-02 |
The General Hospital Corporation |
miRNA profiling compositions and methods of use
|
|
WO2014132137A2
(en)
|
2013-03-01 |
2014-09-04 |
Université De Genève |
Transgenic cell selection
|
|
US10456448B2
(en)
|
2013-03-08 |
2019-10-29 |
The Regents Of The University Of Colorado, A Body Corporate |
PTD-SMAD7 therapeutics
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
EP2968502B1
(de)
|
2013-03-14 |
2020-08-26 |
Bellicum Pharmaceuticals, Inc. |
Verfahren zur steuerung einer t-zellen-proliferation
|
|
WO2014197638A2
(en)
|
2013-06-05 |
2014-12-11 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
|
AU2014317861B2
(en)
|
2013-09-09 |
2019-11-28 |
Figene, Llc |
Gene therapy for the regeneration of chondrocytes or cartilage type cells
|
|
WO2015070050A1
(en)
|
2013-11-08 |
2015-05-14 |
Baylor Research Institute |
Nuclear loclization of glp-1 stimulates myocardial regeneration and reverses heart failure
|
|
WO2015070009A2
(en)
|
2013-11-08 |
2015-05-14 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
|
WO2015082536A1
(en)
|
2013-12-03 |
2015-06-11 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
|
EP3099719B1
(de)
|
2014-01-29 |
2020-04-01 |
Dana-Farber Cancer Institute, Inc. |
Antikörper gegen die muc1-c/extrazelluläre domäne (/muc1-c/ecd)
|
|
WO2015123561A2
(en)
|
2014-02-14 |
2015-08-20 |
University Of Utah Research Foundation |
Methods and compositions for inhibiting retinopathy of prematurity
|
|
CN106132423B
(zh)
|
2014-02-14 |
2020-07-31 |
贝里坤制药股份有限公司 |
用诱导型嵌合多肽活化t细胞的方法
|
|
CA2940765A1
(en)
|
2014-02-25 |
2015-09-03 |
Research Development Foundation |
Sty peptides for inhibition of angiogenesis
|
|
US20170107486A1
(en)
|
2014-04-21 |
2017-04-20 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
|
AU2015312117A1
(en)
|
2014-09-02 |
2017-03-02 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by Myd88 and CD40 polypeptides
|
|
AU2015341481C1
(en)
|
2014-11-03 |
2021-09-16 |
ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) |
T cell receptors directed against Bob1 and uses thereof
|
|
US20180169211A1
(en)
|
2014-11-13 |
2018-06-21 |
Evaxion Biotech Aps |
Peptides derived from acinetobacter baumannii and their use in vaccination
|
|
JP6720176B2
(ja)
|
2014-12-15 |
2020-07-08 |
ベリカム ファーマシューティカルズ， インコーポレイテッド |
治療用細胞のコントロールされた活性化または排除のための方法
|
|
WO2016113252A2
(en)
|
2015-01-12 |
2016-07-21 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting klebsiella pneumoniae
|
|
EP3250675A1
(de)
|
2015-01-28 |
2017-12-06 |
SABIC Global Technologies B.V. |
Verfahren und zusammensetzungen zum hocheffizienten herstellung von biokraftstoff und/oder biomasse
|
|
CA2976236A1
(en)
|
2015-02-09 |
2016-08-18 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides displaying improved complement activation
|
|
WO2016134293A1
(en)
|
2015-02-20 |
2016-08-25 |
Baylor College Of Medicine |
p63 INACTIVATION FOR THE TREATMENT OF HEART FAILURE
|
|
JP2018510627A
(ja)
|
2015-03-10 |
2018-04-19 |
レイデン ユニバーシティ メディカル センター |
メラノーマ優先発現抗原に対して向けられたｔ細胞レセプターおよびその使用
|
|
WO2017005670A1
(en)
|
2015-07-04 |
2017-01-12 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
|
|
US10526408B2
(en)
|
2015-08-28 |
2020-01-07 |
Research Development Foundation |
Engineered antibody FC variants
|
|
DK3365435T3
(da)
|
2015-10-20 |
2021-04-06 |
Fujifilm Cellular Dynamics Inc |
Produktion af hæmatopoietiske prækursorceller med multi-afstamning med genetisk programmering
|
|
MX2018005274A
(es)
|
2015-10-30 |
2019-09-19 |
The Regents Of The Universtiy Of California |
Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t.
|
|
LT3370733T
(lt)
|
2015-11-02 |
2021-10-25 |
Board Of Regents, The University Of Texas System |
Cd40 aktyvinimo ir imuninės kontrolės taškų blokados būdai
|
|
US20190038713A1
(en)
|
2015-11-07 |
2019-02-07 |
Multivir Inc. |
Compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
|
|
PL3373968T3
(pl)
|
2015-11-09 |
2024-08-05 |
The Children's Hospital Of Philadelphia |
Glipikan 2 jako marker nowotworowy i cel terapeutyczny
|
|
GB2545703B
(en)
|
2015-12-22 |
2019-01-09 |
Univ Sheffield |
Apparatus and methods for determining force applied to the tip of a probe
|
|
EP3419654B1
(de)
|
2016-02-22 |
2022-04-27 |
Evaxion Biotech A/S |
In impfstoffen gegen staphylococcus aureus nützliche proteine und nukleinsäuren
|
|
CA3019635A1
(en)
|
2016-03-31 |
2017-10-05 |
Baylor Research Institute |
Angiopoietin-like protein 8 (angptl8)
|
|
WO2017216384A1
(en)
|
2016-06-17 |
2017-12-21 |
Evaxion Biotech Aps |
Vaccination targeting ichthyophthirius multifiliis
|
|
WO2017220787A1
(en)
|
2016-06-24 |
2017-12-28 |
Evaxion Biotech Aps |
Vaccines against aearomonas salmonicida infection
|
|
JP7099967B2
(ja)
|
2016-07-01 |
2022-07-12 |
リサーチ ディベロップメント ファウンデーション |
幹細胞由来移植片からの増殖性細胞の排除
|
|
WO2018015575A1
(en)
|
2016-07-22 |
2018-01-25 |
Evaxion Biotech Aps |
Chimeric proteins for inducing immunity towards infection with s. aureus
|
|
WO2018035429A1
(en)
|
2016-08-18 |
2018-02-22 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of vla-4 and igf-1r
|
|
CN109963590B
(zh)
|
2016-09-02 |
2024-03-15 |
加利福尼亚大学董事会 |
涉及白介素-6受体α结合单链可变片段的方法和组合物
|
|
AU2017340634B2
(en)
|
2016-10-05 |
2022-06-02 |
FUJIFILM Cellular Dynamics, Inc. |
Generating mature lineages from induced pluripotent stem cells with MECP2 disruption
|
|
EP3523423B1
(de)
|
2016-10-05 |
2024-07-31 |
FUJIFILM Cellular Dynamics, Inc. |
Verfahren zur gerichteten differenzierung pluripotenter stammzellen von homozygoten hla-immunzellen
|
|
AU2017375958A1
(en)
|
2016-12-12 |
2019-07-04 |
Multivir Inc. |
Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases
|
|
EP3565576A1
(de)
|
2017-01-05 |
2019-11-13 |
Evaxion Biotech ApS |
Impfstoffe gegen pseudomonas aeruginosa
|
|
KR102668891B1
(ko)
|
2017-04-18 |
2024-05-29 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
항원-특이적 면역 이펙터 세포
|
|
EP3621988A1
(de)
|
2017-05-09 |
2020-03-18 |
Bellicum Pharmaceuticals, Inc. |
Verfahren zur verstärkung oder änderung der signaltransduktion
|
|
AU2018358016A1
(en)
|
2017-11-03 |
2020-05-07 |
Interna Technologies B.V. |
MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
|
|
US11612618B2
(en)
|
2017-11-14 |
2023-03-28 |
Henry Ford Health System |
Compositions for use in the treatment and prevention of cardiovascular disorders resulting from cerebrovascular injury
|
|
JP2021509815A
(ja)
|
2018-01-05 |
2021-04-08 |
オタワ ホスピタル リサーチ インスティチュート |
改変ワクシニアベクター
|
|
WO2019145399A1
(en)
|
2018-01-24 |
2019-08-01 |
Evaxion Biotech Aps |
Vaccines for prophylaxis of s. aureus infections
|
|
AU2019322487B2
(en)
|
2018-03-19 |
2024-04-18 |
Multivir Inc. |
Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancer
|
|
CA3133899A1
(en)
|
2018-03-30 |
2019-10-03 |
University Of Geneva |
Micro rna expression constructs and uses thereof
|
|
WO2020069313A2
(en)
|
2018-09-28 |
2020-04-02 |
Henry Ford Health System |
Use of extracellular vesicles in combination with tissue plasminogen activator and/or thrombectomy to treat stroke
|
|
WO2020083904A1
(en)
|
2018-10-22 |
2020-04-30 |
Evaxion Biotech Aps |
Vaccines targeting m. catharrhalis
|
|
WO2020171889A1
(en)
|
2019-02-19 |
2020-08-27 |
University Of Rochester |
Blocking lipid accumulation or inflammation in thyroid eye disease
|
|
US20220143168A1
(en)
|
2019-02-27 |
2022-05-12 |
Evaxion Biotech A/S |
Vaccines targeting H. influenzae
|
|
WO2020212756A2
(en)
|
2019-04-18 |
2020-10-22 |
Genkin Dmitry Dmitrievich |
Reprogramming of polymorphonuclear leukocytes
|
|
EP3999546A1
(de)
|
2019-07-19 |
2022-05-25 |
The Children's Hospital of Philadelphia |
Chimäre antigenrezeptoren mit glypican-2-bindungsdomänen
|
|
EP4045044A1
(de)
|
2019-10-18 |
2022-08-24 |
The Regents Of The University Of California |
Plxdc-aktivatoren und ihre verwendung zur behandlung von blutgefässstörungen
|
|
WO2021113644A1
(en)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
|
|
EP4087593A1
(de)
|
2020-01-06 |
2022-11-16 |
Evaxion Biotech A/S |
Impfstoffe, die gegen neisseria gonorrhoeae gerichtet sind
|
|
EP4157864A1
(de)
|
2020-05-27 |
2023-04-05 |
Antion Biosciences SA |
Adaptermoleküle zur umleitung von car-t-zellen zu einem antigen von interesse
|
|
MX2022015002A
(es)
|
2020-05-29 |
2023-03-03 |
Fujifilm Cellular Dynamics Inc |
Bicapa del epitelio pigmentario de la retina y fotorreceptores y uso de los mismos.
|
|
IL298085A
(en)
|
2020-05-29 |
2023-01-01 |
Fujifilm Cellular Dynamics Inc |
Retinal pigment epithelium and bicellular photoreceptor aggregates and methods of using them
|
|
EP4263600A1
(de)
|
2020-12-18 |
2023-10-25 |
Century Therapeutics, Inc. |
Chimäre antigenrezeptorsysteme mit anpassbarer rezeptorspezifität
|
|
EP4291216A1
(de)
|
2021-02-09 |
2023-12-20 |
University of Houston System |
Onkolytisches virus zur systemischen abgabe und verbesserten antitumorwirkungen
|
|
US20240122865A1
(en)
|
2021-02-19 |
2024-04-18 |
Pfizer Inc. |
Methods of Protecting RNA
|
|
MX2023011931A
(es)
|
2021-04-08 |
2023-12-15 |
Janssen Biotech Inc |
Materiales y métodos para mejorar la ingenieria de células t de memoria similares a células madre.
|
|
BR112023021993A2
(pt)
|
2021-05-03 |
2024-02-20 |
Astellas Inst For Regenerative Medicine |
Métodos de geração de células endoteliais da córnea madura
|
|
CN117716020A
(zh)
|
2021-05-07 |
2024-03-15 |
安斯泰来再生医药协会 |
产生成熟肝细胞的方法
|
|
WO2022251443A1
(en)
|
2021-05-26 |
2022-12-01 |
FUJIFILM Cellular Dynamics, Inc. |
Methods to prevent rapid silencing of genes in pluripotent stem cells
|
|
EP4366762A1
(de)
|
2021-07-05 |
2024-05-15 |
Evaxion Biotech A/S |
Impfstoffe gegen neisseria gonorrhoeae
|
|
WO2023081813A1
(en)
|
2021-11-05 |
2023-05-11 |
St. Jude Children's Research Hospital, Inc. |
Zip cytokine receptors
|
|
WO2023081894A2
(en)
|
2021-11-08 |
2023-05-11 |
St. Jude Children's Research Hospital, Inc. |
Pre-effector car-t cell gene signatures
|
|
EP4436595A1
(de)
|
2021-11-22 |
2024-10-02 |
Pfizer Inc. |
Verringerung des risikos von antigen-mimetika in immunogenen arzneimitteln
|
|
GB2614309A
(en)
|
2021-12-24 |
2023-07-05 |
Stratosvir Ltd |
Improved vaccinia virus vectors
|
|
WO2023144779A1
(en)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Coronavirus antigen variants
|
|
US20230295661A1
(en)
|
2022-03-16 |
2023-09-21 |
University Of Houston System |
Persistent hsv gene delivery system
|
|
WO2023213393A1
(en)
|
2022-05-04 |
2023-11-09 |
Evaxion Biotech A/S |
Staphylococcal protein variants and truncates
|
|
GB202206507D0
(en)
|
2022-05-04 |
2022-06-15 |
Antion Biosciences Sa |
Expression construct
|
|
WO2023240109A1
(en)
|
2022-06-07 |
2023-12-14 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules for modulating t-cell activity, and uses thereof
|
|
WO2023240182A1
(en)
|
2022-06-08 |
2023-12-14 |
St. Jude Children's Research Hospital, Inc. |
Disruption of kdm4a in t cells to enhance immunotherapy
|
|
WO2023239940A1
(en)
|
2022-06-10 |
2023-12-14 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
|
US20240003871A1
(en)
|
2022-06-29 |
2024-01-04 |
FUJIFILM Cellular Dynamics, Inc. |
Ipsc-derived astrocytes and methods of use thereof
|
|
WO2024059787A1
(en)
|
2022-09-16 |
2024-03-21 |
St. Jude Children's Research Hospital, Inc. |
Disruption of asxl1 in t cells to enhance immunotherapy
|
|
WO2024130212A1
(en)
|
2022-12-16 |
2024-06-20 |
Turnstone Biologics Corp. |
Recombinant vaccinia virus encoding one or more natural killer cell and t lymphocyte inhibitors
|
|
WO2024186630A1
(en)
|
2023-03-03 |
2024-09-12 |
Henry Ford Health System |
Use of extracellular vesicles for the treatment of cancer
|